Prognostic Impact of Baseline Serum C-Reactive Protein in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib

Beuselinck, Benoit; Vano, Yann-Alexandre; Oudard, Stéphane; Wolter, Pascal; De Smet, Robert; Depoorter, Lore; Teghom, Corine; Karadimou, Alexandra; Zucman-Rossi, Jessica; Debruyne, Philip R; Van Poppel, Hendrik; Joniau, Steven; Lerut, Evelyne; Strijbos, Michiel; Dumez, Herlinde; Paridaens, Robert; Van Calster, Ben; Schöffski, Patrick

doi:10.1111/bju.12494

Prognostic Impact of Baseline Serum C-Reactive Protein in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib

Author:

Beuselinck, Benoit

Vano, Yann-Alexandre ; Oudard, Stéphane ; Wolter, Pascal ; De Smet, Robert ; Depoorter, Lore ; Teghom, Corine ; Karadimou, Alexandra ; Zucman-Rossi, Jessica ; Debruyne, Philip R ; Van Poppel, Hendrik ; Joniau, Steven ; Lerut, Evelyne ; Strijbos, Michiel ; Dumez, Herlinde ; Paridaens, Robert ; Van Calster, Ben ; Schöffski, Patrick

Keywords:

Science & Technology, Life Sciences & Biomedicine, Urology & Nephrology, renal cell carcinoma, RCC, sunitinib, prognostic markers, C-reactive protein, INTERFERON-ALPHA, CANCER STATISTICS, TARGETED THERAPY, DOUBLE-BLIND, INTERLEUKIN-6, SURVIVAL, REGRESSION, LEVEL, Adult, Aged, Antineoplastic Agents, Belgium, C-Reactive Protein, Carcinoma, Renal Cell, Disease-Free Survival, Female, France, Humans, Indoles, Kidney Neoplasms, Male, Middle Aged, Pyrroles, Retrospective Studies, Sunitinib, Treatment Outcome, 1103 Clinical Sciences, 3202 Clinical sciences, 3211 Oncology and carcinogenesis

Abstract:

To evaluate the impact of baseline serum C-reactive protein (CRP) level on outcome in metastatic renal cell carcinoma (mRCC) patients treated with sunitinib.